Finance
Finance
Home1AFX • BIT
Carl Zeiss Meditec AG
€25.28
Feb 13, 6:00:00 PM GMT+1 · EUR · BIT · Disclaimer
StockIT listed securityDE headquartered
Previous close
€25.32
Day range
€25.28 - €27.44
Year range
€25.28 - €71.10
Market cap
2.39B EUR
Avg Volume
1.91K
P/E ratio
15.67
Dividend yield
2.18%
Primary exchange
ETR
In the news
Financials
Income Statement
Revenue
Net income
(EUR)Sep 2025Y/Y change
Revenue
627.54M8.27%
Operating expense
261.40M-5.40%
Net income
51.81M-14.68%
Net profit margin
8.26-21.18%
Earnings per share
——
EBITDA
83.01M257.48%
Effective tax rate
19.39%—
Total assets
Total liabilities
(EUR)Sep 2025Y/Y change
Cash and short-term investments
27.27M34.42%
Total assets
3.40B0.30%
Total liabilities
1.28B-4.57%
Total equity
2.13B—
Shares outstanding
87.54M—
Price to book
1.05—
Return on assets
——
Return on capital
6.58%—
Net change in cash
(EUR)Sep 2025Y/Y change
Net income
51.81M-14.68%
Cash from operations
——
Cash from investing
——
Cash from financing
——
Net change in cash
——
Free cash flow
——
About
Carl Zeiss Meditec AG is a multinational medical technology company. Headquartered in Jena, Germany, the company operates as part of the larger Carl Zeiss Group. Doing business as ZEISS Medical Technology, the company develops and manufactures solutions for ophthalmology, dentistry, oncology, neurosurgery, microsurgery, and other medical applications. Founded in 2002, ZEISS Medical Technology employs thousands of professionals worldwide and maintains a presence in dozens of countries around the world. In 2025, the parent company, Carl Zeiss Group, marked 100 years in the United States. In October 2018, Carl Zeiss Meditec won FDA premarket approval for its ReLEx Smile laser system. Also in October 2018, Carl Zeiss Meditec announced the acquisition of Reno, Nevada-based IanTech for an undisclosed sum. In September 2019, Carl Zeiss Meditec launched the CIRRUS 6000 at the European Society of Retina Specialists 2019 Congress. Wikipedia
Founded
2002
Employees
5,784
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for
Search
Clear search
Close search
Google apps
Main menu